DUSP6 and non-small cell lung carcinoma: The total number of tumors was higher in mice injected with H460shDUSP6 cells than in mice injected with H640ns cells (100% vs. 71% respectively) and the number of tumors induced was bigger in H460shDUSP6 cells (50% vs. 20%) which is in accordance with poor prognosis in NSCLC patients with low levels of DUSP6 expression.